Ushio Sankawa
- Molecular Biology top 2%
- Plant Science top 2%
- Pharmacology top 0.5%
- Pharmacology top 0.2%
- Organic Chemistry top 5%
- Co-authors
- Yutaka EbizukaMasaaki ShibuyaIsao FujiiFumiyuki KiuchiShoji ShibataHiroshi NoguchiSatoshi IwakamiTakeshi Kinoshita
- Topics
- Microbial Natural Products and Biosynthesis (23 papers)Natural product bioactivities and synthesis (20 papers)Plant biochemistry and biosynthesis (19 papers)
- Cited by
- PharmacologyToxicology
- Journals
- Journal of Biological ChemistryBiochemical JournalBiochemical and Biophysical Research Communications
- Partner nations
- JapanSouth KoreaUnited States
In The Last Decade
Ushio Sankawa
165 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 131
- Molecular Biology 2.6k
- Plant Science 1.3k
- Pharmacology 1.2k
- Pharmacology 738
- Organic Chemistry 631
Countries citing papers authored by Ushio Sankawa
This map shows the geographic impact of Ushio Sankawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ushio Sankawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ushio Sankawa more than expected).
Fields of papers citing papers by Ushio Sankawa
This network shows the impact of papers produced by Ushio Sankawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ushio Sankawa. The network helps show where Ushio Sankawa may publish in the future.
Co-authorship network of co-authors of Ushio Sankawa
This figure shows the co-authorship network connecting the top 25 collaborators of Ushio Sankawa. A scholar is included among the top collaborators of Ushio Sankawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ushio Sankawa. Ushio Sankawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 58 | |
| 2 | 11 | |
| 3 | 3 | |
| 4 | 64 | |
| 5 | 4 | |
| 6 | 9 | |
| 7 | 3 | |
| 8 | 97 | |
| 9 | 14 | |
| 10 | 5 | |
| 11 | 28 | |
| 12 | 31 | |
| 13 | 66 | |
| 14 | 263 | |
| 15 | 66 | |
| 16 | 35 | |
| 17 | 29 | |
| 18 | 36 | |
| 19 | 71 | |
| 20 | 6 |
About Ushio Sankawa
Ushio Sankawa is a scholar working on Pharmacology, Pharmacology and Toxicology, having authored 165 papers that have together received 4.7k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (23 papers), Natural product bioactivities and synthesis (20 papers) and Plant biochemistry and biosynthesis (19 papers). The work is most often cited by research in Pharmacology (738 citations), Pharmacology (1.2k citations) and Toxicology (212 citations). Ushio Sankawa has collaborated with scholars based in Japan, South Korea and United States. Frequent co-authors include Yutaka Ebizuka, Masaaki Shibuya, Isao Fujii, Fumiyuki Kiuchi, Shoji Shibata, Hiroshi Noguchi, Satoshi Iwakami, Takeshi Kinoshita, Takashi Hakamatsuka and Jung‐Bum Lee. Their work appears in journals such as Journal of Biological Chemistry, Biochemical Journal and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.